logo
Select company
Select metric
-592.14%EBITDA Margin
VS
Market
6
Sector
22
Industry
6
History
65
$ 0.81Close
$ 0.68 - $ 1.6 52-Week Range
Ticker Information

Ticker

SCYX

Company Name

SCYNEXIS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

SCYNEXIS INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SCYX - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -19.29M-592.14%$ 3.26M
3/31/2025$ -26.67M-1013.99%$ 2.63M
12/31/2024$ -20.31M-542.15%$ 3.75M
9/30/2024$ -35.2M-410.94%$ 8.57M
6/30/2024$ -33.61M-347.67%$ 9.67M
3/31/2024$ 104.31M74.31%$ 140.38M
12/31/2023$ 70.89M50.58%$ 140.14M
9/30/2023$ 77.24M56.85%$ 135.87M
6/30/2023$ 50.58M37.29%$ 135.66M
3/31/2023$ -85.05M-1536.79%$ 5.53M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SCYNEXIS INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
  • Over the past 5 years, SCYNEXIS INC's average EBITDA % has been -690.81%.
  • The median EBITDA % for SCYNEXIS INC during this period was -427.93%
  • SCYNEXIS INC reached its highest EBITDA % over the past 5 years at 74.31%.
  • The lowest EBITDA % recorded by SCYNEXIS INC in the same timeframe -2139.83%

SCYNEXIS INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
CAMP : CAMP4 THERAPEUTICS CORP -1603.86%STTK : SHATTUCK LABS INC -1911.68%TXMD : THERAPEUTICSMD INC -5.31%NRXS : NEURAXIS INC -218.34%ALGS : ALIGOS THERAPEUTICS INC -1851.42%DYAI : DYADIC INTERNATIONAL INC -123.19%FEMY : FEMASYS INC -971.78%CPHI : CHINA PHARMA HOLDINGS INC -39.62%PRPH : PROPHASE LABS INC -573.26%IGC : IGC PHARMA INC -432.93%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for SCYNEXIS INC is calculated as follows: EBITDA [ $ -29.02M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

SCYX - EBITDA Margin, Last 5 years

-2139.83%

Minimum

Mar 31, 2022

74.31%

Maximum

Mar 31, 2024

-690.81%

Average

-427.93%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%